June 4, 2021 - Dr. Mark Souweidane, in partnership with Y-mAbs Therapeutics, presented interim phase 1 dose-escalation data for omburtamab for DIPG at virtual ASCO conference.
Sept. 15, 2020 - A generous gift from the HayesTough Foundation will enable Dr. Mark Souweidane and his team take the final steps necessary toward launching the first-ever phase 1 clinical trial specifically designed for children with choroid plexus carcinoma.
JUNE 2020 - ACTA NEUROPATHOLOGICA COMMUNICATIONS features a peer-reviewed article authored by Dr. Jeffrey Greenfield.
April 1, 2020 - At The Children’s Brain Tumor Project, our largest investment is in the dedicated people who work in our lab. Our research initiatives saw an explosion of growth over the past year, and as we embark on new projects we need to expand our team.
Jan. 15, 2020 - The Gift from a Child Initiative, primarily funded by family-founded nonprofit The Swifty Foundation, has designated the Children’s Brain Tumor Project at Weill Cornell Medicine to serve as its fifth named “Center of Excellence” in the US.
October, 2020 - Dr. Jeffrey Greenfield was recently awarded $1.08 million in support of his precision medicine initiative. The generous gift from the Patrick Bayly Marsano Foundation will enable a tremendous increase in defining individualized cancer therapies for children with rare and inoperable pediatric brain tumors.